• Tetracycline Workflows for Selection and Ribosome Studies

  2026-09-14

  Tetracycline combines broad-spectrum bacterial selection with a defined ribosome-centered mechanism that supports practical translation, growth, and membrane-integrity assays. This workflow shows how to prepare C6589 reproducibly, optimize selection without excessive background, and use it responsibly alongside lung adenocarcinoma research workflows inspired by LKB1–telomerase biology.

• PEGylated Iron Oxide Nanoparticles in the Liver

  2026-09-14

  This ACS Nano study separates the effects of iron oxide nanoparticle size and PEG chain length on hepatic biodistribution and cellular uptake. By combining 99mTc-SPECT/CT with primary liver-cell models, it shows that hepatocytes and stellate cells can contribute substantially to uptake, while 2K PEG provides the lowest hepatic accumulation among the tested formulations.

• WAY-100635 in 5-HT1A Pain Circuit Research

  2026-09-13

  WAY-100635 enables selective interrogation of 5-HT1A signaling across receptor-binding, functional, behavioral, and imaging workflows. Its use alongside a 2026 cannabidiol pain study helps separate serotonergic contributions from cannabinoid mechanisms without overstating what the evidence proves.

• From Sialylation Biology to Biotin Detection

  2026-09-12

  A thought-leadership guide connecting ST3GAL1-driven sialylation and Fusobacterium nucleatum adhesion in colorectal cancer with rigorous fluorescent assay design using Streptavidin-FITC.

• From Glucose Flux to Ferroptosis-Resistant HCC

  2026-09-11

  A translational framework for using fluorescent glucose uptake measurements to refine hepatocellular carcinoma resistance studies, while connecting glucose transport phenotypes with the lipid-remodeling and ferroptosis mechanisms reported for HNF4A-AS1.

• XAV-939: Tankyrase Inhibition in Wnt Research

  2026-09-11

  XAV-939, also called NVP-XAV939, is a cell-permeable tankyrase 1 and 2 inhibitor that stabilizes axin and suppresses β-catenin signaling. Its documented research applications include cancer research, fibrotic disease research, osteogenic differentiation, and bone formation disorder studies.

• MDV3100: Rethinking AR Therapy Responses

  2026-09-10

  MDV3100 (Enzalutamide) is more than a benchmark AR antagonist: it is a strategic tool for separating androgen receptor pathway blockade, apoptosis, and reversible senescence-like responses in prostate cancer models.

• Exemestane: From Aromatase Mechanism to Translation

  2026-09-10

  A translational framework for using Exemestane as a steroidal aromatase inhibitor in breast cancer research, combining irreversible target engagement, hormone measurements, biomarker context, and strategic comparison with receptor-directed endocrine approaches.

• Eltanexor Modulates Wnt/β-Catenin in Colorectal Cancer

  2026-09-09

  A 2024 bioRxiv preprint identifies XPO1 inhibition with Eltanexor (KPT-8602) as a potential chemopreventive strategy in colorectal cancer. The study connects nuclear retention of FoxO3a with reduced β-catenin/TCF activity, lower COX-2 expression, and decreased tumor burden in an Apcmin/+ mouse model.

• Tacalcitol Monohydrate: Assay Design Guide

  2026-09-09

  Tacalcitol monohydrate is a synthetic analog of vitamin D3 with applications spanning keratinocyte biology, NGF induction, and colorectal cancer research. This guide presents an orthogonal assay framework that separates VDR-dependent transcription, cell-state effects, and translational interpretation.

• Carbenoxolone disodium: Practical Lab Guide

  2026-09-08

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, gap junction communication, and related signaling. This guide supports cell, tissue, and biochemical workflows with matched controls, while outlining why the compound should not be treated as a selective in vivo efficacy tool or a clinical intervention.

• Auranofin in Redox and Cancer Research

  2026-09-08

  Auranofin provides a mechanistically defined way to perturb thioredoxin reductase, connect redox imbalance with apoptosis, and test radiosensitization. This workflow-focused guide shows how to move from enzyme assays to cell-based, metabolic, antimicrobial, and radiation studies while controlling solvent, dose, and interpretation.

• Fenipentol: From Identity to Assay Design

  2026-09-07

  Fenipentol is a structurally defined small molecule for connecting secretory physiology with receptor and pathway-focused research. This guide emphasizes isomer control, evidence boundaries, formulation, and practical assay decisions rather than repeating conventional pancreatic secretion protocols.

• Pheromone Signaling and Neurodegeneration in C. elegans

  2026-09-07

  Peng et al. show that pheromone exposure during the L1 stage can reprogram neural signaling in C. elegans and accelerate neurodegeneration later in life. The study connects ASK and ASI chemosensory neurons with AIA interneurons, insulin-like signaling, and neuronal autophagy, providing a mechanistic framework for how early environmental information can influence adult proteostasis.

• Sunitinib Workflows for RTK and ATRX Research

  2026-09-05

  Sunitinib enables mechanism-focused studies of angiogenesis, RTK signaling, apoptosis, and genotype-dependent drug sensitivity. This practical workflow connects renal cell carcinoma and nasopharyngeal carcinoma models with the ATRX-stratified glioma findings reported in the reference study.

8657 records 1/578 page Next 12345 下5页 Last page